Clinical Trial Update: o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports completion of a study evaluating tadalafil for prevention of docetaxel-induced peripheral neuropathy in patients with pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Prostate Cancer

Drugs mentioned

• Tadalafil (Cialis) (tadalafil)

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Prostate Cancer Metastatic Disease, Chemotherapy Induced Peripheral Neuropathy (CIPN) | Phase 2 | Status: COMPLETED